CCM
USNA icon

Coe Capital Management’s Usana Health Sciences USNA Stock Holding History

Coe Capital Management’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-60,452
Closed -$2.28M – 247
2014
Q1 		$2.28M Buy
+60,452
New +$2.11M 0.67% 43

Other funds holding USNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Coe Capital Management's USNA Position: Q2 2014 in Review

Coe Capital Management sold out of Usana Health Sciences (USNA) in Q2 2014, closing a stake of 60,452 shares — an estimated $2.28M sold.

Coe Capital Management first reported a position in USNA in Q1 2014 and held it in 1 quarter. The position peaked at $2.28M in Q1 2014. 123 funds tracked by Wall St. Rank hold USNA as of Q2 2014.

  • Coe Capital Management reported no remaining Usana Health Sciences position as of Q2 2014 after selling out during the quarter.
  • Coe Capital Management sold 60,452 Usana Health Sciences shares in Q2 2014, an estimated $2.28M.
  • Coe Capital Management first reported a position in Usana Health Sciences in Q1 2014 and held it in 1 quarter.
  • Coe Capital Management's Usana Health Sciences position peaked at $2.28M in Q1 2014.
  • 123 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2014.

Based on Coe Capital Management's 13F filing for Q2 2014, filed 13 Aug 2014.